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One o f the actua l p ro b lems fo r nowadays is 
tuberculosis’ sickness and death rate. Ukraine as well 
as other ClS countries is the countries with high rate of 
tuberculosis sickness -  indicator for 100 k populations 
is more than 30 cases. The most difficult situation for 
tubercu osis is in Southeast Ukraine region. ln period of 
years 2005-2013 total sickness rate was between 84,1 
(2005 y.) and 70,9 (2013 y.) for 100k population, death 
rate -  25,3 and 18, 0 accordingly. Among children of 
age 0 month -  14 years old sickness rate is 9,3 (2011 y.) 
vs. 11, 1 (2013) cases for 100 k. children population. 
Annual risque of children tuberculosis infection is 0,5 -  
2,0  %. Analysis o f unfavourable te rm ina tion  by  
tuberculosis of Donetsk region children let determinate 
that among dead children 80 % are unvaccinated 
chi dren.
Leading and mandatory prophylactic acti vity of 
tuberculosis control in Ukraine is supposed to be primary 
prophylactic by BCG vaccination that does not prevent 
primary infection and reactivation latent lungs infection 
-  the main source bacilliform spread among population. 
But it is only one existing medicine for nowadays that is 
used for immunization of children against tuberculosis 
and is giving the protection of tuberculosis meningitis 
(64 %), disseminated form of tuberculosis (78 %), lethal 
cases (65 %) by children of young age [1].
In last years BCG -  vaccination influences around 
100 mio children. Efficiency of vaccination BCG is 
proofed by long-term utilization in practical public health 
for more than 90 years long and ability to prevent 
infection generalization by development of local specific 
process secure for children’s health [2-5 ]. Though 
vaccine BCG is alife culture. That’s why it might provoke 
the complication development [6-9 ]. Most complications 
after BCG -  vaccinations reveal as affection of lymphatic 
nodes (axillary, supraclavicular, subraclavicular, cervical) 
by development of specific inflammation that is 
characterized by cheesy nacreous [10-12]. As a reaction 
on BCG -  vaccination might be developed undesirable 
difficult reactions, often systematically connected with 
infection generalization: BCG -  osteomyelitis,
generalized lymphadenopathies, disseminated BCG -  
infection, tuberculosis lupus, frequency of them is 
between 0, 004 and 2, 5 cases [13-16].
In Ukraine the frequency of complication of BCG -  
vaccination in last years is increased in 10-100 times in 
compare to previous epidemics (1946-1990 y.y.) and in 
some regions is 1,5-2,0 % [17-19]. Though risque of 
development of similar complications is much less in 
compare to risque of unvaccinated children. Among 
many reasons of unpredictable reactions of children’s 
organisms to BCG -  vaccination and development of 
serious complications the main are: epidemiological -  
under controlled group of children with AIDS -  influenced 
mothers, who are not registrated being 18 month old; 
decrease of selective pressure to people by contagious 
infected diseases; genetically-screening lack of gens 
polymorphisation process and collection gen’s (point) 
mutation; ignore in children’s organisms of immu­
nological phenomena -  antigen imprinting and antibody- 
mediated activation of infection [9, 17-19, 20-23].
By complication development of BCG -  vaccination 
by children the important role has the immune system 
condition. Hidden changes of immune status by children 
of young age may not clinically reveal themselves [2, 5, 
17, 24, 25].
T hat’s these children don’t have any contra­
indication for BCG-vaccination.
Thereby text above needs new approach by BCG- 
vaccination of children of young age -  differentiated.
The goal of work is integrated valuation of health 
condition of children of young age with BCD-indicated 
regional lymphadenitis.
Materials and methods: under observation there 
were 210 children of yearly age who had the 
complications by BCG vaccinations as regional 
lymphadenitis. Among them there were city children 185 
(91,2 %), village children -  18 (8,8 %). Sexual 
characteristics of vaccinated newborn children were 
approximately equal quantity of male and femal children 
-  53,1 % vs. 46, 9 %. By difficult pregnancy and by 
pathological parturition came 19, 4 % of newborn
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children. Full-term b orne children 95, 3 % and 
prematurely-born -  4,7 %. Background diseases were 
found by 52, 3 % of children: cesarean section (13,2 %), 
acute respiratory disease (9,6 %), anemia (8,5 %), atopic 
dermatitis (14,2 %), perinatal complications of central 
nervous system (19,2 %), prematurely-born 1st degree 
and timomegalia (5,9 % each), pyoinflammatory and VUI 
(6,1 % each), cephalohematoma (2,5 %), hemolytic 
(3,1 %) and hemorrhagical disease (1,5 %), congenital 
heart disease (1,7 %).
Rating of immune status of all the children was lead 
on the bases of complex study of main reactive potential 
indicators on the way of quality and quantity study of 
genogram characteristics on the methodic of N. P. Mel’ 
(1990): weighting -  erythrocyte coefficient (WEC), 
immune -  ly mphocyte potential (ILP), cell -  phagocytize 
indicator (CPI), allergy reaction of organism (ARO).
Discussion and results
In Donetsk region among 69 994 children vaccinated 
by BCG specific complications were developed for 420
children (0,6 %). In condition of maternity department 
of town and sub urb hospitals there were vaccinated 3-5 
days old children 91,4 %, later than 7 days old 5,7 %, 
among them one child: on 17th, 48th day of birth, 3,4 
and 9 months and 2 y .lm .o ld . Prolongation of 
vaccination of children was defined by perinatal defection 
of CNS 5,7 %, morphofunctional immaturity 1,99 %, 
prematurity of 4th degree 0,9 %. Interval of complications 
development from the BCG vaccination moment was 
160,66±36, 8 days in average. In general the 
complications were developed in first half of year of life 
by 72,3 % of children, in next half of year by 19,6 %, 
later by 7,8 %. Clinically complications were revealed 
as infiltrative forms (86,7 %), among them with fistulas 
development -  5, 7 %. Very rare complications by 28 
children (13,3 %) were revealed in following forms: ulcer 
of middle third of shoulder, sternoclavicular combination 
of BCG, tubostatit of right huckle; tubgonit of left knee 
joint.
Specialties of general reactive potential of children’s 
organisms by BCG -  vaccination are presented in table 1.
Table 1
General reactive potential of children’s organisms by BCG -  inducted lymphadenitis in dependence of age
(n=210, M±m)
Age WEC ILP CPI Allergy
0-12 months 0,65+0,08 406,9+7,2 518,4+8,4 130,4+5,6
1 -3 years 0,62+0,03** 657,3+9,1* 858,1+11,2* 319,6+4,9**
Norm 0,50+0,05 471,20+12,80 618,00+17,80 337,10+14,90
Notice: accuracy of variances between both groups *p<0,05, **p>0,05.
Up to dates of table 1 by children of first year of life 
WEC was higher on 30 % than physiological level 
(p<0,05), ILP and CPI were less than physiological level 
on 13,7 % and 16,1 % by absence of allergy statistically 
reliable (p<0,05). Indicators ILP and CPI by children of 
1-3 years old were higher than physiological on 39,4 % 
and 38,8 % by keeping normal indicators WEC and 
Allergy (p<0,05), that shows higher level of inflammatory 
process activity.
Decrease of organisms ability to react on antigen 
irritant and apparent risque of barrier rush on the way 
of infection -  ability of infection generality by children 
of first year of life in compare with children of 1 -3 year 
of life lets j udge ab out higher level of activity of infection- 
inflammatory process and necessity of anti-inflammatory 
therapy, specially by children of first year of life.
For the purpose of control on specific complication 
BCG-vaccination flow as well as on unspecific and 
efficiency of therapy by children of early age, we led
indication of the row of indexes on the grounds of 
enhanced main blood analysis (table 2).
Up to table 2, children of first year of life have 
increased indexes in compare with physiological level: 
LII-1,4 times, RRN -  3,8 , ICL-1,6 and LGI -  1,2; children 
of 2nd and 3rd year of life only RRN increase -1 ,5  times 
(p<0,05). On physiological level by all children are kept 
LII m and only by children of 2-3 years of life LGI. IOR is 
decreased 17,5 times (children of first year of life) and 
2,7 times (children of 2nd and 3rd year). Expressed 
decrease of index of moving of leukocyte in blood in 
compare to physiological level was observed among 
children of 2-3 year of life (2 times), at the same time 
children of first year it was statistically unreliable 
(p>0,05). Index of ratio of leukocytes and ICL was higher 
than physiological level 1,6 times (children of first year 
of life) and 8 times (children 2-3 years old). Mentioned 
above indexes by all children of both groups with BCG 




Specialities of indexes of enhanced hemogram by children with BCG-inducted lymphadenitis of vaccination
(n=210, M±m)
Indicators (units) 0-12 months 1 -3 years Norm
Leukocytic index of intoxication (LII) 0,22+0,03* 0,19+0,04** 0,16+0,02
M odificated leukocytic index of intoxication (LIIm) 0,47+0,06** 0,55+0,03** 0,50+0,04
Reactive response of neutrophils (RRN) 1,47+0,04* 0,60+0,05* 0,39+0,03
Index of organism ’s resistance (IOR) 2,85+0,07* 8,19+0,04* from  50 units to 100 units
Index of moving of leukocyte in blood (IMLB) 0,50+0,03** 0,28+0,04* 0,57+0,05
Index of correlation of leukocyte (ICL) 0,73+0,05* 3,63+0,08* 0,45+0,07
Lym phocytic-granulocytic index (LGI) 17,84+0,03* 14,60+0,08** 15,16+0,11
Notice: accuracy of variances between both groups * p <0,05 **p>0,05.
absence of tissue degradation. Though, RRN states on 
decompensated endogen intoxication, IOR indicates on 
possibility of complications development, ICL lets to 
maintain that intoxication is connected with infection 
process. Dates LGI and IMLB repulse presence of active 
of inflammatory process, probable, of aseptically 
character (p<0,05).
Conclusions
1. BCG-vaccination protects children of early age 
from development of generalized forms of tuberculosis. 
Complications are developing quite rare -  as regional 
lymphadenitis in 0, 6 % of cases.
2. By children of first year of life by BCG-vaccination 
is observed overload of blood flow by products of 
inflammation and intoxication, that indicates to 
decreased ability of organism to react adequate to 
specific antigen irritant and possi bility of risque 
breakthrough of barrier on the way of infection.
3. Complications of BCG-vaccinations mostly are 
evolved by children of first half of year of life (72, 3 %), 
having background disease (52, 3 %).
4. On purpose to prevent complications by children 
of yearly age is required the differentiate approach to 
BCG-vaccinations with a glance to general reacti ve 
potential of organism, existence of background diseases 
and holding of constant screening.
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О С О Б Л И В О С ТІ ЗАГАЛЬНО ГО  
Р Е А К Т И В Н О ГО  П О Т Е Н Ц ІА Л У  Д ІТ Е Й  
РА Н Н Ь О ГО  В ІК У  П Р И  
Б Ц Ж -Л ІМ Ф А Д Е Н ІТ А Х
А.І. Бобровицька, Т.Ф. Голубова, В.В. Суходольська 
РЕЗЮМЕ. У Донецькій області за 3 роки вакцино­
вано вакциною БЦЖ 19078 (Данія) і 14328 (Росія) 
осіб, з них у  210 дітей розвинулися ускладнення: 
143 (0,74 %) дітей були щеплені БЦЖ-вакциною 
(Данія) і 67 (0,46 %) -  БЦЖ-вакциною (Росія). 
Клінічні форми ускладнень в деякій мірі визнача-
лися характером БЦЖ-вакцини. При використанні 
БЦЖ-вакцини (Данія) серед ускладнень у  вигляді 
лімфаденітів різної локалізації частіше в 2,2 рази 
зустрічалися інфільтративні форми, а також за­
значалося наявність нориць (5,7 %) порівняно з 
дітьми, вакцинованими БЦЖ-вакциною (Росія). 
Крім цього, частіше в 3 рази зустрічалися дуже 
рідкісні ускладнення -  10,0 проти 3,3 %. Це ви­
разка середньої третини лівого плеча; ВДТБ, ВТЛ; 
тубостит правого стегна; тубостит нижньої тре­
тини правого стегна; тубостит правої стегнової 
кістки; тубостит лівого колінного суглоба при вак­
цинації БЦЖ-вакциною (Данія). При вакцинації 
БЦЖ -вакциною (Росія) спостерігалися тільки 
ВДТБ, тубостит і ВДТБ, двобічний гоніт. Особли­
вості загального реактивного потенціалу організ­
му при БЦЖ-вакцинації виявляються більш вира­
женим ступенем активності запалення у  дітей ран­
нього віку, а також зниження здатності організму 
відповідати на антигенний подразник і виражений 
ризик прориву бар’єру на шляху інфекції -  мож­
ливість генералізації інфекції у  дітей першого року 
життя на тлі нормальної алергічної налаштованості 
організму. Незважаючи на можливі ускладнення 
при БЦЖ-вакцинації, забезпечення захисту дітей 
раннього віку від генералізованих форм туберку­
льозу можливо шляхом БЦЖ-вакцинації новона­
роджених.
При використанні БЦЖ-вакцини російського 
виробництва спостерігається менше переванта­
ження кровотоку продуктами інтоксикації та за­
палення, більша здатність організму відповідати 
на антигенний подразник, відсутній ризик гене­
ралізації інфекції, особливо у  дітей першого року 
життя, порівняно з БЦЖ-вакциною данського ви­
робництва. Для вакцинації новонароджених про­
ти туберкульозу бажано використовувати більш 
очищену, з високою імуногенністю і найменшою 
реактогенністю БЦЖ-вакцину російського вироб­
ництва. Незважаючи на наявність ускладнень при 
використанні БЦЖ-вакцини, захист організму від 
розвитку генералізованих форм туберкульозу у  
дітей раннього віку можливий шляхом вакцинації 
в період новонародженості.
Ключові слова: загальний реактивний потенці­
ал, діти, БЦЖ-лімфаденіти.
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